Effectiveness of Electroconvulsive Therapy for Preventing Relapse and Recurrence of Depression in Adults With Major Depressive Disorder: An Updated Meta-Analysis of Randomized Clinical Trials

被引:5
|
作者
Dar, Hassaan [1 ]
Vuthaluru, Kiranmayi [2 ]
Folajimi, Atunde [3 ]
Maheshwari, Leladher [4 ]
Shah, Jeet [5 ]
Senaratne, Mithum [6 ]
Pizzorno, Guiomarly [7 ]
Ali, Neelum [8 ]
机构
[1] Jinnah Med & Dent Coll, Res, Islamabad, Pakistan
[2] Jawaharlal Nehru Med Coll, Med, Belgaum, India
[3] NES Healthcare, Neurol, Aylesbury, England
[4] Bahria Univ, Med & Dent Coll, Med Sch, Karachi, Pakistan
[5] Sir Sayajirao Gen Hosp, Med & Surg, Ahmadabad, India
[6] Univ Ruhuna, Med, Matara, Sri Lanka
[7] Univ Carabobo, Gen Med, Orlando, FL USA
[8] Univ Hlth Sci, Internal Med, Lahore, Pakistan
关键词
meta; -analysis; recurrence; relapse; depression; electroconvulsive therapy; CONTINUATION TREATMENT; GUIDELINES; ECT; PHARMACOTHERAPY; EFFICACY; MOOD;
D O I
10.7759/cureus.35683
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The present meta-analysis aimed to assess the impact of electroconvulsive therapy (ECT) in preventing the relapse and recurrence of depression in adults with major depressive disorders. The study was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Two authors conducted a systematic search of online databases, such as PubMed, PsycINFO, and EMBASE, using keywords, such as "electroconvulsive therapy," "depressive disorders," and "recurrence." The primary outcome measure was the incidence of relapse and recurrence in adults with major depressive disorder who received ECT alone or in combination with an antidepressant medication compared to those who received antidepressant medication alone. The secondary outcome measure was the change in the Mini -Mental State Examination score from baseline to the end of the trial in both groups. A total of six articles were included in the meta-analysis. The pooled rate of recurrence in the ECT group was 28.4% compared to 30.6% in the antidepressant group, with no significant difference between the two groups (risk ratio (RR) = 0.84, 95% confidence interval (CI) = 0.65-1.10, p = 0.21). However, subgroup analysis showed that the risk of recurrence was significantly lower in patients receiving ECT with antidepressant therapy compared to the antidepressant group alone (RR = 0.65, 95% CI = 0.45-0.93, p = 0.02). On the other hand, when ECT was given alone, the risk was higher in the ECT group compared to the antidepressant group; however, the difference was not statistically significant (RR = 1.17, 95% CI = 0.79-1.75). In conclusion, the results of this meta-analysis suggest that ECT alone or in combination with an antidepressant medication does not significantly impact the incidence of recurrence in adults with major depressive disorder when compared to antidepressant medication alone.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Electroconvulsive therapy for older adult patients with major depressive disorder: a systematic review of randomized controlled trials
    Dong, Min
    Zhu, Xiao-Min
    Zheng, Wei
    Li, Xiao-Hong
    Ng, Chee H.
    Ungvari, Gabor S.
    Xiang, Yu-Tao
    PSYCHOGERIATRICS, 2018, 18 (06) : 468 - 475
  • [22] Efficacy and adverse effects of ketamine versus electroconvulsive therapy for major depressive disorder: A systematic review and meta-analysis
    Moreira, Debora de A. Simoes
    Gauer, Luis Eduardo
    Teixeira, Guilherme
    da Silva, Amanda Carolina Fonseca
    Cavalcanti, Stefanie
    Quevedo, Joao
    JOURNAL OF AFFECTIVE DISORDERS, 2023, 330 : 227 - 238
  • [23] Comparative effectiveness clinical trial of magnetic seizure therapy and electroconvulsive therapy in major depressive disorder
    El-Deeb, Fatma A.
    Gad, El-Sayed A.
    Kandeel, Ahmed A.
    Haiba, Amr A.
    Fathy, Sameh M.
    Peterson, Meghan M.
    Youssef, Nagy A.
    ANNALS OF CLINICAL PSYCHIATRY, 2020, 32 (04) : 239 - 248
  • [24] A meta-analysis of randomized, placebo-controlled trials of vortioxetine for the treatment of major depressive disorder in adults
    Thase, Michael E.
    Mahableshwarkar, Atul R.
    Dragheim, Marianne
    Loft, Henrik
    Vieta, Eduard
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 (06) : 979 - 993
  • [25] Remifentanil in electroconvulsive therapy: a systematic review and meta-analysis of randomized controlled trials
    Takekita, Yoshiteru
    Suwa, Taro
    Sunada, Naotaka
    Kawashima, Hirotsugu
    Fabbri, Chiara
    Kato, Masaki
    Tajika, Aran
    Kinoshita, Toshihiko
    Furukawa, Toshi A.
    Serretti, Alessandro
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2016, 266 (08) : 703 - 717
  • [26] Problem-solving therapy for major depressive disorders in older adults: an updated systematic review and meta-analysis of randomized controlled trials
    Shang, Pingping
    Cao, Xuelian
    You, Simiao
    Feng, Xuezhu
    Li, Na
    Jia, Yong
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2021, 33 (06) : 1465 - 1475
  • [27] Predictors of depression relapse and recurrence after cognitive behavioural therapy: a systematic review and meta-analysis
    Wojnarowski, Caroline
    Firth, Nick
    Finegan, Megan
    Delgadillo, Jaime
    BEHAVIOURAL AND COGNITIVE PSYCHOTHERAPY, 2019, 47 (05) : 514 - 529
  • [28] Increased BDNF levels after electroconvulsive therapy in patients with major depressive disorder: A meta-analysis study
    Rocha, Renan Boeira
    Dondossola, Eduardo Ronconi
    Grande, Antonio Jose
    Colonetti, Tamy
    Ceretta, Luciane Bisognin
    Passos, Ives C.
    Quevedo, Joao
    da Rosa, Maria Ines
    JOURNAL OF PSYCHIATRIC RESEARCH, 2016, 83 : 47 - 53
  • [29] Evaluating cognitive assessment tools for patients with major depressive disorder receiving electroconvulsive therapy: A systematic review and meta-analysis
    Guo, Qinghua
    Wang, Yong
    Guo, Libo
    Chen, Chao
    Han, Shuyu
    Shang, Shaomei
    ASIAN JOURNAL OF PSYCHIATRY, 2024, 100
  • [30] Randomized Controlled Trials of Psilocybin-Assisted Therapy in the Treatment of Major Depressive Disorder: Systematic Review and Meta-Analysis
    Menon, Vikas
    Ramamurthy, Parthasarathy
    Venu, Sandesh
    Andrade, Chittaranjan
    ACTA PSYCHIATRICA SCANDINAVICA, 2025, 151 (05) : 557 - 571